cifenline has been researched along with Coronary Artery Disease in 1 studies
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuriu, K | 1 |
| Tanaka, H | 1 |
| Hirao, K | 1 |
| Makita, S | 1 |
| Ito, F | 1 |
| Mizuno, T | 1 |
| Tabuchi, N | 1 |
| Arai, H | 1 |
| Sunamori, M | 1 |
1 other study available for cifenline and Coronary Artery Disease
| Article | Year |
|---|---|
Oral cibenzoline reduces postoperative atrial fibrillation in coronary artery bypass grafting.
Topics: Administration, Oral; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Cor | 2005 |